| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |